GB1164313A - Process for Preparing Cross-Linked Proteins and Peptides. - Google Patents

Process for Preparing Cross-Linked Proteins and Peptides.

Info

Publication number
GB1164313A
GB1164313A GB43896/66A GB4389666A GB1164313A GB 1164313 A GB1164313 A GB 1164313A GB 43896/66 A GB43896/66 A GB 43896/66A GB 4389666 A GB4389666 A GB 4389666A GB 1164313 A GB1164313 A GB 1164313A
Authority
GB
United Kingdom
Prior art keywords
peptides
proteins
sept
linked proteins
preparing cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB43896/66A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of GB1164313A publication Critical patent/GB1164313A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB43896/66A 1965-09-30 1966-09-30 Process for Preparing Cross-Linked Proteins and Peptides. Expired GB1164313A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF0047318 1965-09-30

Publications (1)

Publication Number Publication Date
GB1164313A true GB1164313A (en) 1969-09-17

Family

ID=7101559

Family Applications (1)

Application Number Title Priority Date Filing Date
GB43896/66A Expired GB1164313A (en) 1965-09-30 1966-09-30 Process for Preparing Cross-Linked Proteins and Peptides.

Country Status (10)

Country Link
AT (3) AT296339B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE687619A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR6683346D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH503699A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1545863A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK119533B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR1506406A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1164313A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL26586A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6613752A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002838A1 (es) * 1995-07-12 1997-01-30 Francisco Javier Martin Oncina Vacunas polimerizadas

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002838A1 (es) * 1995-07-12 1997-01-30 Francisco Javier Martin Oncina Vacunas polimerizadas
ES2108614A1 (es) * 1995-07-12 1997-12-16 Oncina Fco Javier Martin Vacunas polimerizadas.

Also Published As

Publication number Publication date
AT296339B (de) 1972-02-10
FR1506406A (fr) 1967-12-22
BE687619A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-03-30
BR6683346D0 (pt) 1973-12-26
CH503699A (de) 1971-02-28
IL26586A (en) 1971-03-24
AT297957B (de) 1972-04-25
AT297956B (de) 1972-04-25
DK119533B (da) 1971-01-18
DE1545863A1 (de) 1969-12-11
NL6613752A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-03-31

Similar Documents

Publication Publication Date Title
GB1508050A (en) Bovine milk products
GB2008123A (en) Method of means for microbial polypeptide expression
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
NZ288026A (en) A method for producing influenza hemagglutinin multivalent vaccines
NO940043D0 (no) Peptider av humant papilloma-virus for anvendelse ved human T-cel lerespons, samt blandinger derav
NL182051B (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat met lh/fsh-afgifte teweegbrengende werking, voor de bereiding van peptiden, geschikt voor toepassing in deze preparaten, alsmede gevormd farmaceutisch preparaat.
NL7703115A (nl) Werkwijze ter bereiding van nieuwe peptiden en werkwijze ter bereiding van farmaceutische preparaten, alsmede aldus verkregen gevormde preparaten.
GB1356427A (en) Process for separating glucagon from pancreatic extracts
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
GB1003683A (en) New polypeptides and process for their manufacture
GB1164313A (en) Process for Preparing Cross-Linked Proteins and Peptides.
NZ221379A (en) Nematode plasma membrane-associated protein, extraction method and vaccines containing it
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
GB1437477A (en) Synthetic peptides
EP0257721A3 (en) Vaccine
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
ES387885A1 (es) Metodo de preparacion de sulfato de condroitina.
Naveh et al. Large scale downstream processing of monoclonal antibodies.
NO881661L (no) Humane rhinoviruspeptider.
DE3064798D1 (en) Pentadecapeptide, process for the preparation thereof and immunopotentiating agent
Surovoĭ et al. Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus
NZ219192A (en) Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines
ES2163405T3 (es) Virus recombinantes que comprenden sitios de escision proteoliticos artificiales.
GB1142571A (en) A new polypeptide, and a method of preparing it
Helting Atoxic, immunogenic product of tetanus toxin

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees